SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-106087
Filing Date
2023-10-03
Accepted
2023-10-03 06:01:52
Documents
14
Period of Report
2023-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327123d1_8k.htm   iXBRL 8-K 41553
2 EXHIBIT 99.1 tm2327123d1_ex99-1.htm EX-99.1 243495
  Complete submission text file 0001104659-23-106087.txt   561003

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlsi-20231002.xsd EX-101.SCH 3281
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlsi-20231002_def.xml EX-101.DEF 26921
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlsi-20231002_lab.xml EX-101.LAB 36508
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlsi-20231002_pre.xml EX-101.PRE 25545
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2327123d1_8k_htm.xml XML 4992
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39813 | Film No.: 231301499
SIC: 3841 Surgical & Medical Instruments & Apparatus